HU163979B - - Google Patents

Info

Publication number
HU163979B
HU163979B HUAA695A HUAA000695A HU163979B HU 163979 B HU163979 B HU 163979B HU AA695 A HUAA695 A HU AA695A HU AA000695 A HUAA000695 A HU AA000695A HU 163979 B HU163979 B HU 163979B
Authority
HU
Hungary
Application number
HUAA695A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU163979B publication Critical patent/HU163979B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUAA695A 1971-01-22 1972-01-21 HU163979B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH101271A CH572914A5 (en:Method) 1971-01-22 1971-01-22

Publications (1)

Publication Number Publication Date
HU163979B true HU163979B (en:Method) 1973-12-28

Family

ID=4200381

Family Applications (1)

Application Number Title Priority Date Filing Date
HUAA695A HU163979B (en:Method) 1971-01-22 1972-01-21

Country Status (21)

Country Link
AR (1) AR197293A1 (en:Method)
AT (1) AT313288B (en:Method)
AU (1) AU3767472A (en:Method)
BE (1) BE778269A (en:Method)
CA (1) CA1010041A (en:Method)
CH (1) CH572914A5 (en:Method)
DE (1) DE2164058C3 (en:Method)
DK (1) DK136981B (en:Method)
ES (1) ES398949A1 (en:Method)
FI (1) FI53704C (en:Method)
FR (1) FR2122517B1 (en:Method)
GB (1) GB1377231A (en:Method)
HK (1) HK62577A (en:Method)
HU (1) HU163979B (en:Method)
IL (1) IL38496A (en:Method)
NL (1) NL177116C (en:Method)
OA (1) OA04087A (en:Method)
PL (1) PL88930B1 (en:Method)
SE (1) SE404604B (en:Method)
YU (1) YU35361B (en:Method)
ZA (1) ZA718712B (en:Method)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0174464B1 (de) * 1984-09-14 1990-01-03 ASTA Pharma AG Substituierte Benzylphthalazinon-Derivate
DE3836579A1 (de) * 1987-11-13 1989-05-24 Asta Pharma Ag Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge
IE64051B1 (en) * 1987-11-13 1995-06-28 Asta Medica Ag Azelastine embonate process for its preparation and pharmaceutical preparations which contain azelastine embonate as active substance
EP0316639B1 (de) * 1987-11-13 1994-06-08 ASTA Medica Aktiengesellschaft Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten
ES2053678T3 (es) * 1987-11-13 1994-08-01 Asta Medica Ag Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
DE3912292A1 (de) * 1988-04-20 1989-11-09 Asta Pharma Ag Azelastin enthaltende arzneimittel mit kontrollierter wirkstoffabgabe
US5110814A (en) * 1989-01-11 1992-05-05 Asta Pharma Ag Azelastine and its salts used to combat psoriasis
DK0396069T3 (da) * 1989-05-05 1994-07-25 Asta Medica Ag Salte af azelastin med forbedret opløselighed
DE4207234A1 (de) * 1992-03-07 1993-09-09 Asta Medica Ag Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung
DE4343409C2 (de) * 1993-12-18 1997-03-20 Asta Medica Ag Verbessertes Verfahren zur Herstellung von Hexahydroazepinonen und Hexahydroazepinolen
DE4345224C2 (de) * 1993-12-18 1999-07-01 Asta Medica Ag Verfahren zur Herstellung von Säureadditionssalzen des Azelastins und Flezelastins
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
RS58377B1 (sr) 2004-11-24 2019-04-30 Meda Pharmaceuticals Inc Kompozicije koje sadrže azelastin i metode njihove upotrebe
JP4489143B2 (ja) * 2006-04-20 2010-06-23 グラクソ グループ リミテッド ヒスタミンh1及びh3アンタゴニストとしての2−置換4−ベンジルフタラジノン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1046625B (de) * 1957-08-15 1958-12-18 Hydrierwerk Rodleben Veb Verfahren zur Herstellung basisch substituierter Phthalazone
GB1100911A (en) * 1963-08-20 1968-01-24 Benger Lab Ltd Phthalazine derivatives
DK119061B (da) * 1966-10-28 1970-11-09 Hydrierwerk Rodleben Veb Fremgangsmåde til fremstilling af basisk substituerede phthalazoner eller salte eller kvaternære ammoniumforbindelser deraf.

Also Published As

Publication number Publication date
DE2164058C3 (de) 1981-08-13
DK136981C (en:Method) 1978-06-05
NL177116C (nl) 1985-08-01
NL7200400A (en:Method) 1972-07-25
IL38496A0 (en) 1972-03-28
OA04087A (fr) 1979-10-30
FR2122517B1 (en:Method) 1975-08-01
DK136981B (da) 1977-12-27
CH572914A5 (en:Method) 1976-02-27
FR2122517A1 (en:Method) 1972-09-01
DE2164058B2 (de) 1980-10-23
YU11272A (en) 1980-06-30
HK62577A (en) 1977-12-30
IL38496A (en) 1975-05-22
AU3767472A (en) 1973-07-12
NL177116B (nl) 1985-03-01
GB1377231A (en) 1974-12-11
SE404604B (sv) 1978-10-16
AR197293A1 (es) 1974-03-29
SU440838A3 (en:Method) 1974-08-25
FI53704C (fi) 1978-07-10
YU35361B (en) 1980-12-31
CA1010041A (en) 1977-05-10
FI53704B (en:Method) 1978-03-31
ZA718712B (en) 1972-09-27
ES398949A1 (es) 1975-06-01
PL88930B1 (en:Method) 1976-10-30
AT313288B (de) 1974-02-11
DE2164058A1 (de) 1972-07-27
BE778269A (fr) 1972-07-19

Similar Documents

Publication Publication Date Title
FR2125836A5 (en:Method)
FR2122539B1 (en:Method)
FR2122738A5 (en:Method)
DK141199C (en:Method)
FR2126204A3 (en:Method)
FR2124060B1 (en:Method)
FR2123320B1 (en:Method)
DK136981C (en:Method)
DK138215C (en:Method)
FI49827B (en:Method)
DE2156841A1 (en:Method)
CS175427B2 (en:Method)
FR2125376A1 (en:Method)
FR2126913A1 (en:Method)
DK135118C (en:Method)
FR2124227A1 (en:Method)
FR2121511A1 (en:Method)
FR2125579B1 (en:Method)
FR2125302B1 (en:Method)
DE2125448C3 (en:Method)
FR2126130A2 (en:Method)
FR2123475B1 (en:Method)
FR2126410B1 (en:Method)
FR2124191A1 (en:Method)
DE2159962A1 (en:Method)

Legal Events

Date Code Title Description
HU90 Patent valid on 900628